As the cannabis industry faces tighter margins and harder-to-find profits, many businesses are struggling not just to grow, but to survive.

This year, operators are shifting focus. Instead of chasing expansion, they are being forced to rethink how they grow and, more importantly, how they operate efficiently.

Today, our guest is Matt Morea, co-founder of PrizmGPS, a company focused on what happens after a product hits the shelf.

PrizmGPS helps brands bridge the gap between field sales and in-store execution, bringing a more structured, data-driven approach modeled after industries like alcohol.

As Matt explains, most brands don’t lose performance all at once. They lose it quietly, store by store, as merchandising slips, menus become inconsistent, and reorders grow unpredictable.

The issue is not distribution. It is a lack of visibility into execution.

The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal.

Get in touch with pam@InnovatingCannabisPodcast.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today, we're joined by Duane Boise, CEO of MMJ Holdings, a biopharmaceutical company advancing cannabis-derived medicines through the FDA's botanical Drug Development Pathway. MMJ has received Orphan drug designation for Huntington's disease and multiple sclerosis, and its cannabis-derived soft-gel formulations are now preparing to enter phase 2 clinical trials, helping pave the way for a new era of FDA-validated cannabis medicine.

Duane shares the long road to reaching this milestone, the challenges of bringing cannabis-based therapeutics through the FDA process, and what the future may hold for cannabis as a mainstream medicine.

https://mmjih.com

https://www.linkedin.com/in/duane-boise-b174b9168/

The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal.

Get in touch with pam@InnovatingCannabisPodcast.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Curio Wellness was founded by father-and-daughter team Michael and Wendy Bronfein. Michael built his career in the supermarket industry before launching his own chain of pharmacies, eventually bringing that experience into Maryland's medical cannabis market in 2015.

Since then, Curio has grown into a vertically integrated company with GMP-certified operations in Maryland and Missouri, franchise partnerships in New Jersey and Mississippi, and a recent entry into New York through a licensing deal with Vireo Health.

The company has distinguished itself through a strong focus on research and development, supported by a team of scientists and a commitment to meeting FDA-level standards across its products, cultivation, and manufacturing.

Today, Wendy and her sister, Rebecca Bronfein, are leading the next chapter of Curio Wellness following the passing of their father, Michael, earlier this year.

In this episode, I catch up with Wendy and Rebecca to talk about Curio's operations in Missouri, the evolution of the state's cannabis program, and what lies ahead for the company.

The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal.

Get in touch with pam@InnovatingCannabisPodcast.com.

LinkedIn Twitter Instagram

Please like the show to help us reach more listeners🙏🏻

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.